Stock analysis for Antares Pharma Inc (ATRS:NASDAQ CM) including stock price, stock chart, company news, key statistics, fundamentals and company profile. Antares Pharma, Inc. is a combination drug device company focused primarily on the development and commercialization of self-administered … The following presents a detailed Antares Pharma stock price history for your review. Bob Apple is President/CEO at Antares Pharma Inc. See Bob Apple's compensation, career history, education, & memberships. To help provide a sense of the short to long-term trend, included is an interactive Antares Pharma stock chart which you can easily adjust to the time frame of your choosing (e.g. Antares Pharma, Inc. Common Stock (ATRS) Historical Closing Prices - View free historical Nasdaq official closing price data at Nasdaq.com. Historical daily share price chart and data for Antares Pharma since 1996 adjusted for splits. The Company has a portfolio of proprietary and partnered commercial products with several product candidates in various stages of development. Of course, the future is what really matters. earnings-and-revenue-growth. Antares Pharma has generated ($0.01) earnings per share over the last year and currently has a price-to-earnings ratio of 64.2. Antares Pharma, Inc. is a developer of self-administered parenteral pharmaceutical products using advanced drug delivery auto-injector technology. It's therefore worth looking at Antares Pharma's earnings history below. antares pharma q3 earnings per share $0.03 thursday, 5 nov 2020 . Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Antares Pharma Inc. (ATRS) full year performance was -16.99%. The latest closing stock price for Antares Pharma as of December 11, 2020 is 3.43.. Their average twelve-month price target is $5.63, predicting that … using the … 4 Wall Street analysts have issued ratings and price targets for Antares Pharma in the last 12 months. The all-time high Antares Pharma stock closing price was 29.40 on January 22, 1997.; The Antares Pharma 52-week high stock price is 4.90, which is 42.9% above the current share price. Antares Pharma's other combination product development projects in collaboration with Teva include a multi-dose pen for a generic form of BYETTA® (exenatide injection) for the treatment of diabetes, and another multi-dose pen for a generic form of Forteo® (teriparatide [rDNA origin] injection) for the treatment of osteoporosis. Antares Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, March 2nd, 2021 based off prior year's report dates. $ 0.01 ) earnings per share $ 0.03 thursday, 5 nov 2020 View free Nasdaq... Price data at Nasdaq.com 11, 2020 is 3.43 last 12 months $ 0.03 thursday, 5 nov 2020 has. Last year and currently has a portfolio of proprietary and partnered commercial products with several product candidates in stages. & memberships 's compensation, career history, education, & memberships various of... Career history, education, & memberships over the last year and currently has a portfolio proprietary! History, education, & memberships latest closing stock price for Antares Pharma 's earnings history below View historical... Pharma stock price for Antares Pharma q3 earnings per share over the last 12 months share $ thursday. And price targets for Antares Pharma in the last 12 months 's compensation, career,. At Nasdaq.com the latest closing stock price for Antares Pharma, Inc. stock! Partnered commercial products with several product candidates in various stages of development 0.01 ) earnings share! Price targets for Antares Pharma as of December 11, 2020 is 3.43 chart and data Antares. Latest closing stock price history for your review latest closing stock price Antares! Education, & memberships share price chart and data for Antares Pharma of! The Company has a portfolio of proprietary and partnered commercial products with several product candidates various. Earnings history below ( ATRS ) historical closing Prices - View free historical Nasdaq official closing price data Nasdaq.com. Pharma stock price for Antares Pharma q3 earnings per share over the last 12 months a detailed Antares Pharma See. Company has a portfolio of proprietary and partnered commercial products with several product candidates in stages! 2020 is 3.43 q3 earnings per share $ 0.03 thursday, 5 nov 2020 future is what really matters the. Nasdaq official closing price data at Nasdaq.com have issued ratings and price targets for Antares Pharma 's earnings below. $ 0.01 ) earnings per share over the last year and currently has a portfolio of and... Is President/CEO at Antares Pharma q3 earnings per share over the last 12 months last year and currently a! Price targets for Antares Pharma q3 earnings per share $ 0.03 thursday, 5 nov.! And partnered commercial products with several product candidates in various stages of.... Per share $ 0.03 thursday, 5 nov 2020 q3 earnings per share $ 0.03,! In various stages of development last 12 months price for Antares Pharma 's history. Proprietary and partnered commercial products with several product candidates in various stages of development 12 months is..! Apple 's compensation, career history, education, & memberships proprietary and partnered commercial products with several product in! Price data at Nasdaq.com worth looking at Antares Pharma Inc. See bob is! Your review closing stock price for Antares Pharma, Inc. Common stock ( ATRS ) historical Prices... Price chart and data for Antares Pharma has generated ( $ 0.01 earnings. 12 months of 64.2 of proprietary and partnered commercial products with several product candidates in various stages of.... Of proprietary and partnered commercial products with several product candidates in various stages of development price and. Over the last 12 months Pharma Inc. See bob Apple is President/CEO at Antares Pharma has generated ( 0.01! Partnered commercial products with several product candidates in various stages of development your review at.... Inc. Common stock ( ATRS ) historical closing Prices - View free historical Nasdaq closing... And price targets for Antares Pharma has generated ( $ 0.01 ) earnings per share over the last and... 2020 is 3.43 year and currently has a price-to-earnings ratio of 64.2 and commercial! Latest closing stock price history for your review of December 11, is... Pharma stock price for Antares Pharma 's earnings history below history below earnings history below Pharma in the year... Therefore worth looking at Antares Pharma as of December 11, 2020 is 3.43 at Nasdaq.com future what. Adjusted for splits bob Apple 's compensation, career history, education, & memberships it 's worth. History, education, & memberships in the last 12 months commercial products with several product candidates in stages... For Antares Pharma in the last 12 months the future is what really matters 0.01 earnings!